Gardasil Efficacy In Patients Already Infected With HPV Will Be Addressed By Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
Potential of strains not contained in Merck’s HPV vaccine to offset efficacy of Gardasil will also be discussed at the committee’s May 18 meeting.
You may also be interested in...
Gardasil Efficacy In Adolescent Females Supported By Advisory Committee
FDA’s Vaccines & Related Biological Products Advisory Committee unanimously agrees Merck’s human papillomavirus vaccine is safe and effective for use in females ages nine to 26 years.
Gardasil Efficacy In Adolescent Females Supported By Advisory Committee
FDA’s Vaccines & Related Biological Products Advisory Committee unanimously agrees Merck’s human papillomavirus vaccine is safe and effective for use in females ages nine to 26 years.
Merck Launches HPV Awareness Campaign In Preparation For Gardasil
The firm has launched television, radio and print ads although the HPV vaccine is still pending at FDA.